| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.0B | $17.2B | $14.8B | $15.4B | $7.1B | $1.9B | $1.8B | $1.7B |
| Cost of Revenue | $14.9B | $14.2B | $12.0B | $12.3B | $5.9B | $6.0B | $5.8B | $5.4B |
| Gross Profit | $3.1B | $2.9B | $2.8B | $3.1B | $1.2B | $0.3B | $0.3B | $0.3B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.0B | $1.9B | $1.6B | $1.8B | $0.8B | $0.8B | $0.8B | $0.7B |
| Operating Income | $0.9B | $0.8B | $1.0B | $1.3B | $0.4B | $0.3B | $0.3B | $0.3B |
| Net Income | $0.5B | $0.4B | $0.6B | $1.0B | $0.3B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $25.20 | $21.58 | $28.87 | $44.78 | $13.25 | $2.28 | $2.09 | $2.06 |
| EPS (Diluted) | $25.13 | $21.50 | $28.74 | $44.61 | $13.18 | $2.26 | $2.06 | $2.03 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.6B | $10.3B | $10.2B | $8.0B | $3.7B | $2.9B | $2.7B | $2.4B |
| Current Assets | $3.4B | $3.1B | $3.1B | $1.9B | $1.4B | $1.6B | $1.6B | $1.3B |
| Cash & Equivalents | — | — | — | — | — | $0.0B | $0.0B | $0.0B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $3.6B | $2.8B | $2.9B | $1.0B | $1.2B | $1.2B | $1.3B | $1.1B |
| Stockholders' Equity | $3.9B | $3.5B | $3.2B | $2.9B | $0.9B | $0.6B | $0.5B | $0.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.8B | $0.7B | $0.3B | $0.7B | $0.7B | $0.3B | $0.0B | $0.3B |
| Investing Cash Flow | $-1.5B | $-0.1B | $-1.7B | $0.5B | $-0.8B | $-0.2B | $-0.1B | $-0.1B |
| Capital Expenditures | — | — | — | — | — | $0.1B | $0.0B | $0.0B |
| Financing Cash Flow | $0.7B | $-0.5B | $1.2B | $-1.1B | $0.2B | $-0.1B | $0.1B | $-0.1B |